BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Ribavirin
1
Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C
12/2/2022 12:50:19 PM | Browse: 183 | Download: 499
2
Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages
6/24/2021 7:26:32 AM | Browse: 351 | Download: 633
3
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over
9/21/2020 4:02:08 PM | Browse: 545 | Download: 1176
4
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
5/6/2019 10:43:10 AM | Browse: 837 | Download: 1200
5
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
4/4/2018 1:15:45 PM | Browse: 1052 | Download: 1427
6
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
12/5/2017 1:55:00 AM | Browse: 928 | Download: 1497
7
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM | Browse: 1259 | Download: 1654
8
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection
2/6/2017 9:08:00 AM | Browse: 915 | Download: 1747
9
Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
1/22/2017 8:28:00 AM | Browse: 1196 | Download: 1852
10
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
11/18/2016 3:13:00 PM | Browse: 970 | Download: 1911
11
Retrospective study of the associations between hepatitis C virus infection and metabolic factors
10/25/2016 8:46:00 AM | Browse: 1373 | Download: 1982
12
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
10/12/2016 2:18:00 PM | Browse: 1080 | Download: 1105
13
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience
8/3/2016 8:11:00 AM | Browse: 1341 | Download: 1834
14
Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
3/2/2016 1:35:00 PM | Browse: 1582 | Download: 2538
15
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
2/25/2016 7:04:00 PM | Browse: 1059 | Download: 1709
16
Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
2/22/2016 3:38:00 PM | Browse: 1023 | Download: 1902
17
Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-/ribavirin therapy
1/23/2016 5:08:00 PM | Browse: 1330 | Download: 1582
18
Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C
1/20/2016 5:04:00 PM | Browse: 988 | Download: 1445
19
Ribavirin: Past, present and future
1/15/2016 9:49:00 AM | Browse: 1260 | Download: 1320
20
Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management
1/15/2016 9:49:00 AM | Browse: 985 | Download: 1159
21
Hepatitis C genotype 4: The past, present, and future
12/4/2015 3:24:00 PM | Browse: 1212 | Download: 1970
22
Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients
12/2/2015 12:20:00 PM | Browse: 1499 | Download: 1473
23
Hepatitis C in hemodialysis patients
12/2/2015 12:01:00 PM | Browse: 1025 | Download: 1182
24
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development
11/27/2015 5:17:00 PM | Browse: 1255 | Download: 1960
25
Hepatitis E virus infection: Epidemiology and treatment implications
11/12/2015 5:09:00 PM | Browse: 1071 | Download: 1828
26
Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance
11/9/2015 6:35:00 PM | Browse: 1188 | Download: 1291
27
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens
6/29/2015 4:40:00 PM | Browse: 1177 | Download: 1848
28
Hepatitis C: New challenges in liver transplantation
5/20/2015 5:01:00 PM | Browse: 1001 | Download: 1717
29
Natural interferon-beta treatment for patients with chronic hepatitis C in Japan
5/19/2015 5:28:00 PM | Browse: 1134 | Download: 1405
30
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study
5/18/2015 5:02:00 PM | Browse: 1187 | Download: 1319
31
Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection
5/18/2015 5:02:00 PM | Browse: 881 | Download: 1239
32
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control
3/30/2015 5:46:00 PM | Browse: 1159 | Download: 1644
33
Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6
3/13/2015 3:29:00 PM | Browse: 1168 | Download: 1458
34
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings
2/11/2015 5:56:00 PM | Browse: 1310 | Download: 1647
35
Retreatment with peginterferon and ribavirin in chronic hepatitis C
2/11/2015 5:56:00 PM | Browse: 983 | Download: 1162
36
Study of pruritus in chronic hepatitis C patients
12/20/2014 9:24:00 PM | Browse: 1070 | Download: 1338
37
Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection
12/5/2014 11:43:00 AM | Browse: 1109 | Download: 1302
38
New treatments for chronic hepatitis C: an overview for paediatricians
12/5/2014 11:43:00 AM | Browse: 1275 | Download: 1675
39
Telaprevir/boceprevir era: From bench to bed and back
9/16/2014 8:07:00 PM | Browse: 1339 | Download: 1337
40
Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients
9/16/2014 4:56:00 PM | Browse: 1005 | Download: 660
41
Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C
9/16/2014 3:23:00 PM | Browse: 956 | Download: 703
42
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation
9/15/2014 8:53:00 PM | Browse: 1174 | Download: 1006
43
Hepatitis C, stigma and cure
9/12/2014 8:41:00 PM | Browse: 1243 | Download: 937
44
Hepatitis C genotype 6: A concise review and response-guided therapy proposal
9/10/2014 4:40:00 PM | Browse: 1092 | Download: 904
45
Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy
9/5/2014 2:19:00 PM | Browse: 956 | Download: 941
46
Challenges in managing hepatitis C virus infection in cancer patients
9/1/2014 2:51:00 PM | Browse: 925 | Download: 667
47
Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection
9/1/2014 2:51:00 PM | Browse: 1092 | Download: 993
48
Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
8/28/2014 5:50:00 PM | Browse: 1412 | Download: 950
49
Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
8/26/2014 3:10:00 PM | Browse: 1105 | Download: 1055
50
Emerging therapeutic options for the management of hepatitis C infection
8/26/2014 2:46:00 PM | Browse: 969 | Download: 790